Aug 11, 2026 06:53AM
Aug 10, 2026 04:24PM
Jun 12, 2026 08:10AM
May 12, 2026 04:01PM
Apr 15, 2026 04:01PM
Apr 15, 2026 04:01PM
Nov 11, 2025 04:57AM Nkarta Inc. (NKTX) PT Lowered to $11 at Stifel
Nov 10, 2025 04:01PM
Aug 13, 2024 09:03PM
Aug 13, 2024 04:01PM
Jul 16, 2024 06:01AM
Jul 16, 2024 06:01AM
Jun 27, 2024 06:01AM
Jun 27, 2024 06:00AM Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
Mar 21, 2024 04:01PM
Jan 9, 2024 10:25AM
Nov 9, 2023 04:02PM
Oct 17, 2023 07:01AM
Oct 17, 2023 07:01AM
Aug 11, 2022 04:02PM
Apr 26, 2022 08:54AM Pre-Open Stock Movers 04/26: MagnaChip Gains on Deal Talk; Universal Health, GE Dip on Earnings (more...)
Apr 25, 2022 08:54AM
Mar 17, 2022 04:03PM
Mar 17, 2022 04:02PM
Dec 16, 2021 08:02AM
Dec 16, 2021 08:02AM
Oct 7, 2021 04:02PM
Oct 7, 2021 04:01PM Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
Jul 16, 2021 09:30AM
May 13, 2021 04:02PM
Apr 28, 2021 08:10AM
Apr 28, 2021 08:02AM
Mar 25, 2021 04:03PM
Nov 12, 2020 04:03PM
Nov 9, 2020 08:05AM Nkarta (NKTX) Announces Presentation of Preclinical Data on NKX019, Engineered NK Cell Therapy Candidate Targeting CD19, at the Annual Meeting of the Society for Immunotherapy of Cancer
Nov 9, 2020 08:02AM
Aug 20, 2020 04:02PM

328,140 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All